In a recent study, inhibition of FBXL2 may also promote apoptosis and limit tumor growth in PTEN-null cancers where PTEN has been identified as a counteractor of FBXL2 in binding with IP3R3 (a major player in Ca+ dependent apoptosis) for ubiquitin mediated degradation 11. This evidence concerns the gene FBXL2 and neoplasm.